Screener
USANA Health Sciences USNA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | As of April 4,2026 | As of January 3, 2026 |
|---|---|---|
| Redeemable noncontrolling interest | 51,236 | 53,168 |
| Stockholders' equity | ||
| Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 18,457 as of April 4, 2026 and 18,281 as of January 3, 2026 | 18 | 18 |
| Additional paid-in capital | 84,733 | 83,544 |
| Retained earnings | 473,235 | 465,720 |
| Accumulated other comprehensive income (loss) | (14,436) | (16,178) |
| Total stockholders' equity attributable to USANA | 543,550 | 533,104 |
| Total liabilities, redeemable noncontrolling interest, and stockholders' equity | $738,966 | $742,915 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's total equity?
- USANA Health Sciences (USNA) reported total equity of $543.55M in Q1 2026.
- How has USANA Health Sciences's total equity changed year-over-year?
- USANA Health Sciences's total equity increased by 2.6% year-over-year, from $529.76M to $543.55M.
- What is the long-term trend for USANA Health Sciences's total equity?
- Over 5 years (2020 to 2025), USANA Health Sciences's total equity has grown at a 3.8% compound annual growth rate (CAGR), from $441.65M to $533.1M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about USANA Health Sciences's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude